Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor medication used to treat attention deficit hyperactivity...
70 KB (6,105 words) - 23:27, 23 July 2024
(Edronax), developed as a first-line therapy for major depressive disorder. Atomoxetine (Strattera) is another potent and selective NRI which is also effective...
34 KB (3,819 words) - 14:10, 24 July 2024
non-stimulant medications, atomoxetine and viloxazine, are approved by the FDA and in other countries for the treatment of ADHD. Atomoxetine, due to its lack of...
258 KB (27,284 words) - 14:32, 4 August 2024
the following: Selective norepinephrine reuptake inhibitors Marketed Atomoxetine (Strattera) Reboxetine (Edronax, Vestra) Viloxazine (Qelbree, Vivalan)...
7 KB (627 words) - 19:38, 15 February 2024
effect. For ADHD, the effectiveness of methylphenidate is comparable to atomoxetine but modestly lower than amphetamines, alleviating the executive functioning...
148 KB (13,712 words) - 02:25, 3 August 2024
an extended-release form, latterly with comparable effectiveness to atomoxetine and methylphenidate. Side effects of viloxazine include insomnia, headache...
35 KB (3,017 words) - 04:42, 22 July 2024
Non-stimulant medications with a specific indication for ADHD include atomoxetine (Strattera), viloxazine (Qelbree), guanfacine (Intuniv), and clonidine...
168 KB (15,901 words) - 18:19, 23 July 2024
studies on medical treatments are limited, however, research suggests that atomoxetine and lisdexamfetamine may be used to treat CDS. The condition was previously...
55 KB (6,315 words) - 07:11, 1 August 2024
Idiopathic hypersomnia (section Atomoxetine)
because of the high dosage required and potential for severe side effects. Atomoxetine (or reboxetine in Europe) is an adrenergic reuptake inhibitor which increases...
48 KB (5,215 words) - 07:00, 7 May 2024
trial found that the combination of piracetam and atomoxetine was more effective than atomoxetine alone. While piracetam may be an effective adjuvant...
24 KB (2,356 words) - 12:45, 14 July 2024